Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer
Oncologist - United States
doi 10.1634/theoncologist.2015-0508
Full Text
Open PDFAbstract
Available in full text
Date
June 27, 2016
Authors
Publisher
Alphamed Press